Fever Control Using External Cooling in Mechanically Ventilated Patients With Septic Shock
Key facts
- Who runs it
- Centre Hospitalier Intercommunal Creteil
- Where
- France33 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 820 people, planned
- Started
- 1 Oct 2022
- Expected to end
- 1 Dec 2028
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- External Cooling
- Record updated
- 21 September 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 19 criteriaShow less
Who can take part
- Documented or suspected infection either communautary or hospital acquired
- Septic shock defined by the need for vasopressor and lactate>2 mmol/l despite adequate fluid resuscitation (sepsis-3 definition)
- Patients under invasive mechanical ventilation
- Body core temperature>38.3°C
- Intravenous sedation or opioids
- Ongoing antimicrobial treatment and/or intervention for infection source control
- Attending physician confirms clinical equipoise without substantial risk if the patient participates in the trial
- Informed consent of next of kin/other designated person before inclusion or procedure for inclusion in emergency situation
Who cannot take part
- Cardiac arrest within previous 7 days
- Acute brain injury within previous 7 days
- <18 years old
- Extensive burns or epidermal necrolysis
- Body core temperature >41°C
- Under legal guardianship
- No affiliation with the French health-care system
- Pregnancy
- Participation in another interventional study with mortality as the primary endpoint
- An investigator's decision not to resuscitate
- Patient already recruited in the trial
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The best strategy for managing fever in patients with septic shock remains unknown. In a pilot study, the investigators showed that fever control at normothermia allowed a better control of shock and evolution of organ failures. In this second trial the investigators will conduct a multicentre, open-label, randomized controlled, superiority trial in which two strategies will be compared:
Read full original descriptionShow less
1. Respect of fever 2. Fever control at normothermia using external cooling The primary end point will be d-60 mortality.
The 2 groups in the trial
- Fever Control by external coolingTreatment being tested
External cooling during 48 hours to obtain normothermia
Treatment: External Cooling
- Fever respected, no coolingNo study treatment, for comparison
Fever respect without any antipyretic therapy
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Intérêt du Traitement de la fièvre Par Refroidissement Externe Pour la Survie Des Patients ventilés en Choc Septique
- Publications
- Record updated
- 21 September 2026